Letter to the editor
- PMID: 37950411
- DOI: 10.1111/jvp.13417
Letter to the editor
References
REFERENCES
-
- EMA, The European Agency for the Evaluation of Medical Products (EMA). (2019a). Committee for Medical Products for Veterinary Use. CVMP Assessment Report for Forceris. https://www.ema.europa.eu/en/documents/assessment-report/forceris-epar-p...
-
- EMA, The European Agency for the Evaluation of Medical Products (EMA). (2019b). Committee for Medical Products for Veterinary Use. CVMP Assessment Report for Baycox Iron. https://www.ema.europa.eu/en/documents/assessment-report/baycox-iron-epa...
-
- EMA, The European Medicines Agency for the Evaluation of Medicinal Products (EMA). (2009). Committee for Medicinal Products for Human Use (CHMP). Guidelines on Bioanalytical Method Validation, EMEA/CHMP/EWP/192217/. https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-bi...
-
- Lim, J. H., Kim, M. S., Hwang, Y. H., Song, I. B., Park, B. K., & Yun, H. I. (2010). Pharmacokinetics of toltrazuril and its metabolites, toltrazuril sulfoxide and toltrazuril sulfone, after a single oral administration to pigs. The Journal of Veterinary Medical Science, 72(8), 1085-1087. https://doi.org/10.1292/jvms.09-0524
-
- Yeh, T. W., Rairat, T., Wang, C. M., Wu, C. F., Huang, S. W., Chou, C. C., & Kuo, H. C. (2023). Pharmacokinetics of toltrazuril and its metabolite, toltrazuril sulfone, in suckling piglets following oral and intramuscular administrations. Journal of Veterinary Pharmacology and Therapeutics, 1-12. https://doi.org/10.1111/jvp.13405